Free Trial

Blue Owl Capital Co. III (OBDE) Competitors

$16.48
+0.22 (+1.35%)
(As of 05/31/2024 ET)

OBDE vs. MSDL, BCSF, CVII, TRIN, CION, AACT, FSNB, SBEA, ENGN, and OHI

Should you be buying Blue Owl Capital Co. III stock or one of its competitors? The main competitors of Blue Owl Capital Co. III include Morgan Stanley Direct Lending (MSDL), Bain Capital Specialty Finance (BCSF), Churchill Capital Corp VII (CVII), Trinity Capital (TRIN), CION Investment (CION), Ares Acquisition Co. II (AACT), Fusion Acquisition Corp. II (FSNB), SilverBox Engaged Merger Corp I (SBEA), enGene (ENGN), and Omega Healthcare Investors (OHI).

Blue Owl Capital Co. III vs.

Morgan Stanley Direct Lending (NYSE:MSDL) and Blue Owl Capital Co. III (NYSE:OBDE) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation, community ranking and risk.

In the previous week, Blue Owl Capital Co. III had 2 more articles in the media than Morgan Stanley Direct Lending. MarketBeat recorded 6 mentions for Blue Owl Capital Co. III and 4 mentions for Morgan Stanley Direct Lending. Blue Owl Capital Co. III's average media sentiment score of 0.05 beat Morgan Stanley Direct Lending's score of -0.14 indicating that Morgan Stanley Direct Lending is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Morgan Stanley Direct Lending
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Blue Owl Capital Co. III
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Morgan Stanley Direct Lending currently has a consensus target price of $21.92, indicating a potential downside of 5.33%. Blue Owl Capital Co. III has a consensus target price of $16.00, indicating a potential downside of 2.91%. Given Morgan Stanley Direct Lending's stronger consensus rating and higher possible upside, analysts plainly believe Blue Owl Capital Co. III is more favorable than Morgan Stanley Direct Lending.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Morgan Stanley Direct Lending
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Blue Owl Capital Co. III
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Morgan Stanley Direct Lending received 4 more outperform votes than Blue Owl Capital Co. III when rated by MarketBeat users. However, 100.00% of users gave Blue Owl Capital Co. III an outperform vote while only 45.45% of users gave Morgan Stanley Direct Lending an outperform vote.

CompanyUnderperformOutperform
Morgan Stanley Direct LendingOutperform Votes
5
45.45%
Underperform Votes
6
54.55%
Blue Owl Capital Co. IIIOutperform Votes
1
100.00%
Underperform Votes
No Votes

Blue Owl Capital Co. III has a net margin of 63.33% compared to Blue Owl Capital Co. III's net margin of 62.34%. Morgan Stanley Direct Lending's return on equity of 13.62% beat Blue Owl Capital Co. III's return on equity.

Company Net Margins Return on Equity Return on Assets
Morgan Stanley Direct Lending62.34% 12.87% 6.39%
Blue Owl Capital Co. III 63.33%13.62%6.78%

Morgan Stanley Direct Lending pays an annual dividend of $2.00 per share and has a dividend yield of 8.6%. Blue Owl Capital Co. III pays an annual dividend of $1.40 per share and has a dividend yield of 8.5%. Morgan Stanley Direct Lending pays out 64.5% of its earnings in the form of a dividend. Blue Owl Capital Co. III pays out 61.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Blue Owl Capital Co. III has higher revenue and earnings than Morgan Stanley Direct Lending. Blue Owl Capital Co. III is trading at a lower price-to-earnings ratio than Morgan Stanley Direct Lending, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Morgan Stanley Direct Lending$367.74M5.63$231.01M$3.107.47
Blue Owl Capital Co. III$422.83M4.81$271.96M$2.277.26

Summary

Blue Owl Capital Co. III beats Morgan Stanley Direct Lending on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OBDE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OBDE vs. The Competition

MetricBlue Owl Capital Co. IIIHolding Offices IndustryFinance SectorNYSE Exchange
Market Cap$2.03B$362.92M$9.81B$17.85B
Dividend Yield8.50%7.48%5.98%3.55%
P/E Ratio7.265.0743.0124.78
Price / Sales4.8113.20104.0911.18
Price / Cash7.6361.3216.1918.91
Price / Book1.0674.753.305.90
Net Income$271.96M$23.63M$1.01B$976.46M
7 Day Performance1.42%5.60%0.39%0.62%
1 Month Performance8.78%-0.24%2.43%3.61%
1 Year PerformanceN/A-1.12%15.33%20.81%

Blue Owl Capital Co. III Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MSDL
Morgan Stanley Direct Lending
0.4729 of 5 stars
$23.11
+0.5%
$21.92
-5.2%
N/A$2.07B$367.74M7.45N/A
BCSF
Bain Capital Specialty Finance
1.7168 of 5 stars
$16.55
+0.3%
$16.33
-1.3%
+34.1%$1.07B$297.79M8.281,000Analyst Upgrade
Short Interest ↓
Positive News
CVII
Churchill Capital Corp VII
0 of 5 stars
$10.73
-0.3%
N/A+4.8%$982.44MN/A0.002Short Interest ↑
TRIN
Trinity Capital
1.3648 of 5 stars
$14.83
+0.8%
$15.50
+4.5%
+15.9%$727.83M$181.85M9.2173
CION
CION Investment
1.5997 of 5 stars
$12.47
+0.4%
$11.75
-5.7%
+30.6%$668.00M$251.01M5.11N/AShort Interest ↑
AACT
Ares Acquisition Co. II
0 of 5 stars
$10.65
flat
N/AN/A$665.31MN/A0.00N/AShort Interest ↑
High Trading Volume
FSNB
Fusion Acquisition Corp. II
0 of 5 stars
$10.49
flat
N/AN/A$655.63MN/A0.00N/AHigh Trading Volume
SBEA
SilverBox Engaged Merger Corp I
0 of 5 stars
$6.04
-3.7%
N/A+7.6%$517.87MN/A0.005Gap Down
ENGN
enGene
2.6146 of 5 stars
$10.50
-17.6%
$34.40
+227.6%
N/A$457.59MN/A0.0031Short Interest ↓
OHI
Omega Healthcare Investors
3.2136 of 5 stars
$31.54
+2.4%
$33.63
+6.6%
+9.4%$7.79B$949.74M28.4157Short Interest ↑
Positive News

Related Companies and Tools

This page (NYSE:OBDE) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners